« Back
Home /
786-O Cells

786-O Cells

Für die Verwendung dieses Produktes fordert der Hersteller das zu Ihrer Institution passende, ausgefüllte und unterschriebene Formular:

Profit Organisation/Nutzung: CLS_CLEAR.pdf
Non-Profit Organisation/Nutzung: Non_Profit_CLS_Supply_Agreement.pdf

Bitte laden Sie dieses entweder beim Kaufabschluss hoch oder senden es alternativ an die purchasing@hoelzel.de

Item no.	CLS-300107
Manufacturer	CLS Cell Lines Service
Amount	1 cryovial
Category	Cell Lines & Cell Culture Cell Lines
Type	Cell line
Certificate	For a certificate of analysis, please send an inquiry to info@hoelzel.de.
Specific against	Human (Homo sapiens)
Dry ice	Yes
ECLASS 10.1	42040401
ECLASS 11.0	42040401
UNSPSC	41106509
Alias	786-o,786O,786-0,786.O,786-O RCC,RCC 786-O,RCC_7860,RCC 7860,7860,786-0WT
Available
Manufacturer - Applications	This cell line is an optimal choice for transfection.
Manufacturer - Category	Kidney cancer cell lines
Description	786-O cells are a human renal cell carcinoma cell line derived from a primary clear cell adenocarcinoma of the kidney. This cell line is frequently used in the study of renal cell carcinoma (RCC), providing valuable insights into the biological characteristics and treatment responses of this cancer type. The 786-O cell line exhibits a clear cell morphology, typical of the most common form of kidney cancer, and is characterized by specific genetic alterations, including the loss of the von Hippel-Lindau (VHL) tumor suppressor gene. This genetic feature is significant as it plays a crucial role in the pathogenesis of many clear cell renal carcinomas by influencing hypoxia-inducible pathways, which are central to cellular responses to low oxygen conditions. These cells are particularly useful for studying the molecular mechanisms involved in tumor growth and survival, including pathways related to angiogenesis, metabolism, and cell cycle regulation. Due to their VHL deficiency, 786-O cells are an excellent model for researching the effects of hypoxia and for testing drugs that target hypoxia-related pathways. In addition to their application in basic cancer research, 786-O cells are also used in preclinical studies to evaluate the efficacy of new therapeutic agents, especially those targeting the angiogenic processes driven by the overexpression of hypoxia-inducible factors (HIFs). This includes therapies that inhibit the HIF pathway, tyrosine kinase inhibitors, and immune checkpoint inhibitors. Overall, 786-O cells provide a robust model for advancing our understanding of the molecular underpinnings of renal cell carcinoma and for developing targeted therapies that could improve treatment outcomes for patients with this challenging disease.
Tissue	Kidney
Growth properties	Monolayer, adherent
Disease	Renal cell carcinoma
Age	58 years
Gender	Male
Ethnicity	Caucasian
Morphology	Epithelial-like
Biosafety Level	1
Culture Medium	RPMI 1640, w: 2.1 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Medium Supplements	Supplement the medium with 10% FBS
Subculturing	Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
Fluid Renewal	2 to 3 times per week
Freezing Recovery	After thawing, plate the cells at 4 x 10^4 cells/cm^2 and allow the cells to recover from the freezing process and to adhere for at least 48 hours.
Freeze Medium	CM-1 (Cytion catalog number 800100)
Handling of Cryopreserved Cultures	Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit. Upon receipt, either store the cryovial immediately at temperatures below -150° C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required. For immediate culturing, swiftly thaw the vial by immersing it in a 37° C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
Sterility	Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.
Safety Precautions	When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
Disclaimer	Our cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting.
Warranty	We stand by the promise of delivering products with high cell viability and robust culture performance. To achieve the best results, please make sure you follow the storage and culture instructions detailed in the product information sheet closely. Your adherence to these guidelines is key to success.
Amelogenin	X, Y
Tumorigenic	In immunosuppressed hamsters
Split Ratio	A ratio of 1:4 to 1:12 is recommended
Seeding Density	1 x 10^4 cells/cm^2 will result in a confluent monolayer within 4 days.
Doubling Time	24 hours
Antigen Expression	CAIX +, as confirmed by FACS analysis.
Ploidy Status	Hypertriploid. Y chromosome was observed in 60% of the cells analyzed.
Products	The cells produce a PTH (parathyroid hormone) like peptide that is identical to peptides produced by breast and lung tumors. It has an N terminal sequence similar to PTH, has PTH like activity, and has a molecular weight of 6000 daltons.
Karyotype	Hypertriploid. Y was present in 60% of cells examined

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CLS-300107-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1 cryovial

available

Delivery expected until 10/30/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer